235 related articles for article (PubMed ID: 34504347)
1. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing.
Fang LT; Zhu B; Zhao Y; Chen W; Yang Z; Kerrigan L; Langenbach K; de Mars M; Lu C; Idler K; Jacob H; Zheng Y; Ren L; Yu Y; Jaeger E; Schroth GP; Abaan OD; Talsania K; Lack J; Shen TW; Chen Z; Stanbouly S; Tran B; Shetty J; Kriga Y; Meerzaman D; Nguyen C; Petitjean V; Sultan M; Cam M; Mehta M; Hung T; Peters E; Kalamegham R; Sahraeian SME; Mohiyuddin M; Guo Y; Yao L; Song L; Lam HYK; Drabek J; Vojta P; Maestro R; Gasparotto D; Kõks S; Reimann E; Scherer A; Nordlund J; Liljedahl U; Jensen RV; Pirooznia M; Li Z; Xiao C; Sherry ST; Kusko R; Moos M; Donaldson E; Tezak Z; Ning B; Tong W; Li J; Duerken-Hughes P; Catalanotti C; Maheshwari S; Shuga J; Liang WS; Keats J; Adkins J; Tassone E; Zismann V; McDaniel T; Trent J; Foox J; Butler D; Mason CE; Hong H; Shi L; Wang C; Xiao W;
Nat Biotechnol; 2021 Sep; 39(9):1151-1160. PubMed ID: 34504347
[TBL] [Abstract][Full Text] [Related]
2. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing.
Xiao W; Ren L; Chen Z; Fang LT; Zhao Y; Lack J; Guan M; Zhu B; Jaeger E; Kerrigan L; Blomquist TM; Hung T; Sultan M; Idler K; Lu C; Scherer A; Kusko R; Moos M; Xiao C; Sherry ST; Abaan OD; Chen W; Chen X; Nordlund J; Liljedahl U; Maestro R; Polano M; Drabek J; Vojta P; Kõks S; Reimann E; Madala BS; Mercer T; Miller C; Jacob H; Truong T; Moshrefi A; Natarajan A; Granat A; Schroth GP; Kalamegham R; Peters E; Petitjean V; Walton A; Shen TW; Talsania K; Vera CJ; Langenbach K; de Mars M; Hipp JA; Willey JC; Wang J; Shetty J; Kriga Y; Raziuddin A; Tran B; Zheng Y; Yu Y; Cam M; Jailwala P; Nguyen C; Meerzaman D; Chen Q; Yan C; Ernest B; Mehra U; Jensen RV; Jones W; Li JL; Papas BN; Pirooznia M; Chen YC; Seifuddin F; Li Z; Liu X; Resch W; Wang J; Wu L; Yavas G; Miles C; Ning B; Tong W; Mason CE; Donaldson E; Lababidi S; Staudt LM; Tezak Z; Hong H; Wang C; Shi L
Nat Biotechnol; 2021 Sep; 39(9):1141-1150. PubMed ID: 34504346
[TBL] [Abstract][Full Text] [Related]
3. Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays.
Kadri S; Long BC; Mujacic I; Zhen CJ; Wurst MN; Sharma S; McDonald N; Niu N; Benhamed S; Tuteja JH; Seiwert TY; White KP; McNerney ME; Fitzpatrick C; Wang YL; Furtado LV; Segal JP
J Mol Diagn; 2017 Jan; 19(1):43-56. PubMed ID: 27836695
[TBL] [Abstract][Full Text] [Related]
4. Whole genome and exome sequencing reference datasets from a multi-center and cross-platform benchmark study.
Zhao Y; Fang LT; Shen TW; Choudhari S; Talsania K; Chen X; Shetty J; Kriga Y; Tran B; Zhu B; Chen Z; Chen W; Wang C; Jaeger E; Meerzaman D; Lu C; Idler K; Ren L; Zheng Y; Shi L; Petitjean V; Sultan M; Hung T; Peters E; Drabek J; Vojta P; Maestro R; Gasparotto D; Kõks S; Reimann E; Scherer A; Nordlund J; Liljedahl U; Foox J; Mason CE; Xiao C; Hong H; Xiao W
Sci Data; 2021 Nov; 8(1):296. PubMed ID: 34753956
[TBL] [Abstract][Full Text] [Related]
5. Validated WGS and WES protocols proved saliva-derived gDNA as an equivalent to blood-derived gDNA for clinical and population genomic analyses.
Kvapilova K; Misenko P; Radvanszky J; Brzon O; Budis J; Gazdarica J; Pos O; Korabecna M; Kasny M; Szemes T; Kvapil P; Paces J; Kozmik Z
BMC Genomics; 2024 Feb; 25(1):187. PubMed ID: 38365587
[TBL] [Abstract][Full Text] [Related]
6. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM
BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759
[TBL] [Abstract][Full Text] [Related]
7. Deep whole-genome sequencing of 3 cancer cell lines on 2 sequencing platforms.
Arora K; Shah M; Johnson M; Sanghvi R; Shelton J; Nagulapalli K; Oschwald DM; Zody MC; Germer S; Jobanputra V; Carter J; Robine N
Sci Rep; 2019 Dec; 9(1):19123. PubMed ID: 31836783
[TBL] [Abstract][Full Text] [Related]
8. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
9. Systematic comparison of germline variant calling pipelines cross multiple next-generation sequencers.
Chen J; Li X; Zhong H; Meng Y; Du H
Sci Rep; 2019 Jun; 9(1):9345. PubMed ID: 31249349
[TBL] [Abstract][Full Text] [Related]
10. Benchmarking workflows to assess performance and suitability of germline variant calling pipelines in clinical diagnostic assays.
Krishnan V; Utiramerur S; Ng Z; Datta S; Snyder MP; Ashley EA
BMC Bioinformatics; 2021 Feb; 22(1):85. PubMed ID: 33627090
[TBL] [Abstract][Full Text] [Related]
11. Improving somatic exome sequencing performance by biological replicates.
Cebeci YE; Erturk RA; Ergun MA; Baysan M
BMC Bioinformatics; 2024 Mar; 25(1):124. PubMed ID: 38519906
[TBL] [Abstract][Full Text] [Related]
12. Evaluating somatic tumor mutation detection without matched normal samples.
Teer JK; Zhang Y; Chen L; Welsh EA; Cress WD; Eschrich SA; Berglund AE
Hum Genomics; 2017 Sep; 11(1):22. PubMed ID: 28870239
[TBL] [Abstract][Full Text] [Related]
13. Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection.
Lee AY; Ewing AD; Ellrott K; Hu Y; Houlahan KE; Bare JC; Espiritu SMG; Huang V; Dang K; Chong Z; Caloian C; Yamaguchi TN; ; Kellen MR; Chen K; Norman TC; Friend SH; Guinney J; Stolovitzky G; Haussler D; Margolin AA; Stuart JM; Boutros PC
Genome Biol; 2018 Nov; 19(1):188. PubMed ID: 30400818
[TBL] [Abstract][Full Text] [Related]
14. MosaicHunter: accurate detection of postzygotic single-nucleotide mosaicism through next-generation sequencing of unpaired, trio, and paired samples.
Huang AY; Zhang Z; Ye AY; Dou Y; Yan L; Yang X; Zhang Y; Wei L
Nucleic Acids Res; 2017 Jun; 45(10):e76. PubMed ID: 28132024
[TBL] [Abstract][Full Text] [Related]
15. Personalized genomic analyses for cancer mutation discovery and interpretation.
Jones S; Anagnostou V; Lytle K; Parpart-Li S; Nesselbush M; Riley DR; Shukla M; Chesnick B; Kadan M; Papp E; Galens KG; Murphy D; Zhang T; Kann L; Sausen M; Angiuoli SV; Diaz LA; Velculescu VE
Sci Transl Med; 2015 Apr; 7(283):283ra53. PubMed ID: 25877891
[TBL] [Abstract][Full Text] [Related]
16. Analysis of tumor mutational burden: correlation of five large gene panels with whole exome sequencing.
Heydt C; Rehker J; Pappesch R; Buhl T; Ball M; Siebolts U; Haak A; Lohneis P; Büttner R; Hillmer AM; Merkelbach-Bruse S
Sci Rep; 2020 Jul; 10(1):11387. PubMed ID: 32647293
[TBL] [Abstract][Full Text] [Related]
17. FFPE breast tumour blocks provide reliable sources of both germline and malignant DNA for investigation of genetic determinants of individual tumour responses to treatment.
Wilkins A; Chauhan R; Rust A; Pearson A; Daley F; Manodoro F; Fenwick K; Bliss J; Yarnold J; Somaiah N
Breast Cancer Res Treat; 2018 Aug; 170(3):573-581. PubMed ID: 29700676
[TBL] [Abstract][Full Text] [Related]
18. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
[TBL] [Abstract][Full Text] [Related]
19. Archived neonatal dried blood spot samples can be used for accurate whole genome and exome-targeted next-generation sequencing.
Hollegaard MV; Grauholm J; Nielsen R; Grove J; Mandrup S; Hougaard DM
Mol Genet Metab; 2013; 110(1-2):65-72. PubMed ID: 23830478
[TBL] [Abstract][Full Text] [Related]
20. Identification of high-confidence somatic mutations in whole genome sequence of formalin-fixed breast cancer specimens.
Yost SE; Smith EN; Schwab RB; Bao L; Jung H; Wang X; Voest E; Pierce JP; Messer K; Parker BA; Harismendy O; Frazer KA
Nucleic Acids Res; 2012 Aug; 40(14):e107. PubMed ID: 22492626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
